Summary: Pregnant rats were subcutaneously injected twice daily with JL5 ml 150 mmol/1 MgCh beginning at day 5 of gestation. By this treatment development of foetal liver and pancreas was enhanced. In the foetal liver, there was a precocious glycogenolysis combined with a precocious development of the smooth endoplasmic reticulum (ER) and an irregulär arrangement of the rough ER. In the pancreas, the development of secretory granules was enhanced.
Introduction
In tocolytic therapy with ß-agonists 20.5% of the newborns exhibit hypotrophy according to the chosen score. When, during tocolysis, patients were supplemented with Mg 2+ (15-20 mmol/day), only 8.8% of the newborns were hypotrophic, i.e. the same frequency of occurence äs in normal pregnancy (8-11%) (l). When pregnant rats were injected daily with MgSO 4 (150 mg/kg body weight) from day 5 of pregnancy, the foetal livers at term 'were well developed with morphofunctional features closely resembling those of the adult organs (2) .
From these observations, it seems that chronic Mg 2 * supplementation during pregnancy may enhance foetal development. We therefore investigated foetal development, to find at which stage of pregnancy it is enhanced by Mg 2 *, which foetal Organs are concerned, and the nature of the biochemical mechanism responsible for the effect.
Materials and Methods
Wistar rats weighing 200 g were used in the experiments. The rats were maintained under a 12-hour light-dark cycle and at a temperature of about 20 °C. Virgin females were mated from 8-10 a. m. and impregnated females were identified by the presence of copulatory plugs. This day was designated äs day 0 of gestation. The animals were fed with Altromin (Altromin, Lage, FRG) (Mg 2+ content: 83 mmol/kg, Ca 2+ content: 220 mmol/kg) and tap water (Mg 2 * content: 0.5 mmol/1) ad libitum.
Morphology
Some of the pregnant rats were subcutaneously injected twice per day at 9 a.m. and 4 p.m. with 1.5 ml 150 mmol/I MgCb. At day 10, 11, 12, 13, 15, 17, 19, 20 and 21 of pregnancy, two Mg 2+ -injected and one control rat were killed. Up to day 13 the number of somites was calculated. Foetuses from day 10 to 17 were fixed in toto in 30 g/l paraformaldehyde and 30 g/l glutaraldehyde in 0.2 mol/1 cacodylate buffer pH 7.2 for electron microscopy and in 35 g/l formaldehyde for light microscopy and alizarin red-staining. From day 19-21, separated tissues were fixed for electron microscopy and histology. For electron microscopy, postfixation was performed in 10 g/l OsC>4 in cacodylate buffer pH 7.2, followed by dehydration in ethanol, embedding in Mikropal, sectioning with Reichert and LKB microtomes, and contrasting in uranyl acetate/lead citrate. Electron microscopy was performed with Zeiss EM 10 and Siemens 101. For histology, slices were stained in haematoxilin-eosin (HE).
For detection of skeletal development, foetuses from day 19 to 21 were fixed in formalin, stained with alizarin red, cleared in NaOH, and stored in glycerol.
Mg

2+ metabolism
To determine whether MgCb injected into the mothers is taken up by foetal tissues, pregnant rats were injected 7 times every 4 hours with 1.5 ml 150 mmol/1 MgCh beginning from day 18 at 9 a. m. At day 19, the rats were killed at various times after the last injection.
Foetal blood, heart, liver and maternal blood were taken under pentobarbital (Nembutal®) anesthesia (50 mg/kg). For experimental details see I.e. (3).
In a second experiment, after laparotomy in pentobarbital anesthesia, half of the foetuses in each pregnant rat were s.c. injected with 75 150 mmol/1 MgCh. After two hours, foetal blood, heart, liver, and maternal blood were taken.
Foetal hearts and livers were freeze-dried. 
Results
Growth rate
When pregnant rats, fed with the normal Mg 2 * rieh food, were injected with MgCla from day 5, the number of the somites in the foetuses at day 10, 11, 12 and 13 was unchanged (tab. 1). Also the weight of the foetuses at day 20 and 21 was unaltered (tab. 2). Therefore, growth rate was not affected under our conditions of Mg 2+ supplementatiori.
Tab. l. Number of somites of foetuses frorn MgCh-injected and untreated pregnant rats. Mean ± SEM, n = number of foetuses. 
Morphology
Liver
The deposition of glycogen, usually beginning at day 17, was the same in both foetal groups. Höwever, beginning at day 19, the glycogen content was lower in the Mg
2+
-treated foetuses than in the controls. From day 20 to 21, in the Mg 2+ -treated foetuses, the glycogen content decreased, whereas in the cpritrols, glycogen increased further. Fröm this result one can conclude that the lower glycogen content in the Mg 2+ -treated group is caused by glycogenolysis. Parallel with the reduction of glycogen content, there was an increase in the amount of smootfo endoplasmic reticulüm (ER). The rough ER, normally ordered in parallel was in part irregularly arranged and in contact with mitochondria. Siitiilär behaviour was seen when the biosynthesis of mitochondria was enftanced (4). Gell membranes, mitochondria and nucleus of the hepatocytes were not affected by Mg Other cell types of the foetal liver were not significantly changed. The accelerated development by Mg 2 +-injection did not reach the adult state; adult liver still has less glycogen and more smooth ER than foetal liver after Mg 2 +-treatment.
Adrenals
As glucocorticoid hormones play a permissive role in glycogen synthesis in foetal liver (5), the development of the adrenals was electronmicroscopically investigated. However, there were no significant qualitative morphological differences in the development of foetal adrenals from untreated and MgCl2-treated pregnant rats.
Pancreas
As insulin and glucagon are involved in the regulation of glycogen metabolism and s the ratio insulin/ glucagon is perinatally changed (6), the behaviour of pancreatic islets was investigated. The foetal pancreatic islets from MgC^-treated pregnant rats showed no changes in the normal pattern of development, and significant morphological differences between the control foetuses and those from MgCl 2 -treated mothers were not observed.
However, the development of the excretory part of the pancreas was enhanced by MgCla-treatment. Beginning from day 17 and more expressed at later stages, the excretory cells from MgCl 2 -treated foetuses contain more ER and excretory vesicles than those from untreated controls. Some material was already excreted into the ductus ( fig. 3 ). 
Lung, kidney
In the lungs and kidneys of foetuses from MgCb-injected and non-injected pregnant rats, no significant morphological alterations could be seen by light and electron microscopy.
Skeleton
In the foetuses of MgC^-injected mothers, the pattern of the skeleton was not altered but the mineralization of all bones was reduced in Alizarin redstained and cleared specimens. This could be seen best in the tail. As the bones of the tail are the last to be mineralized, the number of tail vertebrae was lower than in the controls (fig. 4) . This result is in agreement with in-vitro mineralization experiments. 45 Ca 2+ incorporation in bone was also reduced by competition with Mg 2+ , when the extracellular Mg 2+ concentration was increased (7).
In pregnant rats, subcutaneously injected every 4 hours with 1.5ml 150 mmol/1 MgCl 2 , the serum Mg 2+ concentration 30 min p.i. was increased to 3.1 mmol/1 and dropped rapidly to 1.2 mmol/1 within 4 hours after injection ( fig. 5 ). This subsequent fall is due to excretion and to the adsorption of Mg Therefore, in a second expefiment, foetal serum Mg 
Discussion
The most significant result of our experiments was the accelerated development of the foetal livers by MgCk-treatment of their mothers.
From our morphological results, the decrease of glycogen and the development of smooth ER seem to be combined. As the mechanism for the enhanced development of foetal liver by Mg 2+ treatment, an increase of the intracellular concentration of Mg 2+ or other electrolytes can be excluded, becaüse the cellular electrolyte contents were not changed by the increase in extracellular Mg 2+ concentration. This also holds for the drastic increase in foetal serum Mg 2+ concentration by direct s.c. injection into the foetuses. Therefore, the precocious decrease of liver glycogen combined with the precocious development of ER may be produced by other mechanisms. These may be an altered foetal hormone secretion and/or an altered activity of regulatory enzymes of glycogen metabolism.
As the onset and early deposition of glycogen occurs at the normal time point in both groups (day 17), the permissive role of glucocorticoid hormones seems to be unaltered by maternal Mg 24 " treatment, in agreement with the absence of any morphological alteration of adrenal development.
From a consideration of the biochemical actions of insulin and glucagon, a reduction of the insulin/glucagon ratio could explain the reduction of foetal liver glycogen by glycogenolysis. In normal foetal rats, the insulin/glucagpn ratio decreased during the last 2-3 days of gestation (6, 8, 9) . However, at the same time, the liver glycogen content increases considerably (5, 8, 9) . Therefore, the regulation of glycogen in foetal liver seems to be more complicated, becaüse of the involvement of other components e.g. Ca 2+ , hormone receptors, adenylate cyclase, cAMP-phosphodiesterase, glycogensynthetase, phosphorylase, phosphorylase phosphatase, synthetase phosphatase (10) . Their catalytic activities change during foetal development (8, 9) , and their kinetic properties are different from the enzymes in adult liver (8) , although they have not been defined in detail.
Thus, the precocious glycogenolysis after Mg 2+ -treatment, may result from an enhanced reduction of the insülin/glucagon ratio.
An altered extracellular Mg 2+ /Ca 2+ -competition at the islet cell membrane is a possible explanation for an altered foetal hormone secretion. When pancreatic islets (from adult animals) were incubated with increased Mg 2+ -concentration at constant Ca 2+ -concentration, insulin secretion was decreased (11, 12) , although this effect was only significant at rather high Mg 2 " l "-concentration (11, 12) . However, it is not known whether insulin and glucagon secretion of foetal pancreatic islets shows the same sensitivity to increased extracellular Mg 2+ äs in the adult pancreas.
As glucose-6-phosphatase is bound to ER, the enhanced development of this organeile after Mg 2+ -treatment may be evidence for increased glycogenolysis by another mechanism. This enzyme, inducible by glucagon (8) , can reduce the glucose-6-phosphate concentration. As glucose-6-phosphate is an allosteric activator of glycogen synthetase, a precocious decrease in glucose-6-phosphate may be responsible for a lower synthesis of glycogen and thus a precocious decrease in glycogen content.
However, other enzymes, regulating synthesis and degradation of glycogen may be also changed by the Mg 2+ -treatment. Moreover, MgCl 2 -treatment may change the concentration of intracellular free Ca 2+ , which is also involved in glycogen metabolism (10) .
Because of the very low cytosolic Ca 2 + concentration and strong compartmentalization, the partidpation of Ca 2+ cannot be determined by measuring the total Ca 2+ content of the liver. More experiments are needed to clarify the regulatofy rnechanisms of glycogen metabolism in normal and Mg^-treated foetal livers. The enhanced development of excretory pancreas may be related to the enhanced development of its ER. The mechanism may ! be simiiar to the increase of ER in the foetal liver after Mg 2+ -tfeatment.
